English and American drug clients' views of the acceptability, advantages, and disadvantages of treatment and harm reduction interventions

Journal of Drug Issues

Volumn 37, Issue 2, 2007, Pages 377-402

  Phillips, Kristina T ^a   Rosenberg, Harold ^b   Sanikop, Ajat ^c  

^a UNIVERSITY OF NORTHERN COLORADO   (United States)

^b BOWLING GREEN STATE UNIVERSITY   (United States)

^c West Midlands Deanery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547479159     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204260703700208     Document Type: Article

References (24)

1. Akhurst, J.S. 1999 The use of lofexidine by drug dependency units in the United Kingdom. European Addiction Research, 5, 43-49.
2. Bammer, G., Dance, P., Stevens, A., Mugford, S., Ostini, R., & Crawford, D. 1996 Attitudes to a proposal for controlled availability of heroin in Australia: Is it time for a trial? Addiction Research, 4, 45-55.
3. Bradbeer, T.M., Fleming, P.M., Charlton, P., & Crichton, J.S. 1998 Survey of amphetamine prescribing in England and Wales. Drug and Alcohol Review, 17, 299-304.
4. Brewer, C. 1997 Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation. Addiction Biology, 2, 291-302.
5. Broadhead, R.S., Kerr, T.H., Grund, J-P., C., & Altice, F.L. 2002 Safer injection facilities in North America: Their place in public policy and health initiatives. Journal of Drug Issues, 32, 329-356.
6. Burris, S., Norland, J., & Edlin, B.R. 2001 Legal aspects of providing naloxone to heroin users in the United States. International Journal of Drug Policy, 12, 237-248.
7. Denning, P. 2001 Strategies for implementation of harm reduction in treatment settings. Journal of Psychoactive Drugs, 33, 23-26.
8. Fleming, P.M., & Roberts, D. 1994 Is the prescription of amphetamine justified as a harm reduction measure? Journal of the Royal Society of Health, 114, 127-131.
9. Hunter, G.M., Stimson, G.V., Judd, A., Jones, S., & Hickman, M. 2000 Measuring injecting risk behaviour in the second decade of harm reduction: A survey of injecting drug users in England. Addiction, 95, 1351-1361.
10. Hurley, S.F., Jolley, D.J., & Kaldor, J.M. 1997 Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349, 1797-1800.
11. Ling, W., Huber, A., & Rawson, R. 2001 New trends in opiate pharmacotherapy. Drug and Alcohol Review, 20, 79-94.
12. MacCoun, R.J. 1998 Toward a psychology of harm reduction. American Psychologist, 53, 1199-1208.
13. Marsch, L.A. 1998 The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction, 93, 515-532.
14. Ogborne, A.C., & Birchmore-Timney, C. 1998 Support for harm-reduction among staff of specialized addiction treatment services in Ontario, Canada. Drug and Alcohol Review, 17, 51-58.
15. Rao, S., & Schottenfeld, R. 1999 Methadone maintenance. In R.J. Ott, R.E. Tarter, & R.T. Ammerman (Eds.), Sourcebook on substance abuse: Etiology, epidemiology, assessment, and treatment (pp. 362-372). Boston: Allyn & Bacon.
16. Rehm, J., Gschwend, P. Steifen, T., Gutzwiller, F., Dobler-Mikola, A.., & Uchtenhagen, A. 2001 Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: A follow-up study. Lancet, 358, 1417-1420.
17. Rich, J.D., Whitlock, T.L., Towe, C.W., McKenzie, M., Runarsdottir, V., & Aboagye-Kumi, M. 2001 Prescribing syringes to prevent HIV: A survey of infectious disease and addiction medicine physicians in Rhode Island. Substance Use and Misuse, 36, 535-550.
18. Rosenberg, H., Melville, J., & McLean, P.C. 2002 Acceptability and availability of pharmacological interventions for substance misuse by British NHS services. Addiction, 97, 59-65.
19. Rosenberg, H., & Phillips, K.T. 2003 Acceptance and availability of innovative and harm-reduction therapies for drug abuse in American substance abuse treatment agencies. Psychology of Addictive Behaviors, 17, 203-210.
20. Sell, L., Farrell, M., & Robson, P. 1997 Prescription of diatnorphine, dipipanone and cocaine in England and Wales. Drug and Alcohol Review, 16, 221-226.
21. Sell, L. & Zador, D. 2004 Patients prescribed injectable heroin or methadone: Their opinions and experiences of treatment. Addiction, 99, 442-449.
22. Shearer, J., Wodak, A., Mattick, R.P., Van Beek, I., Lewis, J., & Hall, W. 2001 Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction, 96, 1289-1296.
23. Strang, J., Powis, B., Best, D., Vingoe, L., Griffiths, P., & Taylor, C. 1999 Preventing opiate overdose fatalities with take-home naltrexone: Pre-launch study of possible impact and acceptability. Addiction, 94, 199-204.
24. Strang, J., & Sheridan, J. 1997 Prescribing amphetamines to drug misusers: Data from the 1995 national survey of community pharmacies in England and Wales. Addiction, 92, 833-838.